Published in Blood on March 15, 2002
Platelet adhesive dynamics. Part II: high shear-induced transient aggregation via GPIbalpha-vWF-GPIbalpha bridging. Biophys J (2008) 1.32
Fluid shear induces conformation change in human blood protein von Willebrand factor in solution. Biophys J (2009) 1.03
Platelet deposition in non-parallel flow: influence of shear stress and changes in surface reactivity. J Math Biol (2008) 0.89
AFM of biological complexes: what can we learn? Curr Opin Colloid Interface Sci (2008) 0.85
Analysis of the role of von Willebrand factor, platelet glycoprotein VI-, and α2β1-mediated collagen binding in thrombus formation. Blood (2014) 0.78
Facilitating roles of murine platelet glycoprotein Ib and alphaIIbbeta3 in phosphatidylserine exposure during vWF-collagen-induced thrombus formation. J Physiol (2004) 0.78
Oligomerization of DDR1 ECD affects receptor-ligand binding. J Struct Biol (2013) 0.76
Role of fluid shear stress in regulating VWF structure, function and related blood disorders. Biorheology (2015) 0.75
Decreased ADAMTS-13 (A disintegrin-like and metalloprotease with thrombospondin type 1 repeats) is associated with a poor prognosis in sepsis-induced organ failure. Crit Care Med (2007) 2.37
Thrombotic thrombocytopenic purpura directly linked with ADAMTS13 inhibition in the baboon (Papio ursinus). Blood (2010) 1.75
Binding of von Willebrand factor to collagen and glycoprotein Ibalpha, but not to glycoprotein IIb/IIIa, contributes to ischemic stroke in mice--brief report. Arterioscler Thromb Vasc Biol (2010) 1.74
Matrix-specific suppression of integrin activation in shear stress signaling. Mol Biol Cell (2006) 1.67
Deficiency of von Willebrand factor protects mice from ischemic stroke. Blood (2009) 1.65
Lipid rafts and the local density of ErbB proteins influence the biological role of homo- and heteroassociations of ErbB2. J Cell Sci (2002) 1.48
Functional genomics in zebrafish permits rapid characterization of novel platelet membrane proteins. Blood (2008) 1.45
Platelet microparticle formation and thrombin generation under high shear are effectively suppressed by a monoclonal antibody against GPIba. Thromb Haemost (2006) 1.43
Shielding of the A1 domain by the D'D3 domains of von Willebrand factor modulates its interaction with platelet glycoprotein Ib-IX-V. J Biol Chem (2005) 1.34
Platelets at work in primary hemostasis. Blood Rev (2011) 1.34
Computer program for determining fluorescence resonance energy transfer efficiency from flow cytometric data on a cell-by-cell basis. Comput Methods Programs Biomed (2004) 1.33
IL-2 and IL-15 receptor alpha-subunits are coexpressed in a supramolecular receptor cluster in lipid rafts of T cells. Proc Natl Acad Sci U S A (2004) 1.25
Platelet receptor interplay regulates collagen-induced thrombus formation in flowing human blood. Blood (2003) 1.18
Transcription profiling in human platelets reveals LRRFIP1 as a novel protein regulating platelet function. Blood (2010) 1.16
von Willebrand factor to the rescue. Blood (2009) 1.13
Novel calibration method for flow cytometric fluorescence resonance energy transfer measurements between visible fluorescent proteins. Cytometry A (2005) 1.06
Platelet adhesion to collagen. Thromb Res (2011) 1.04
Restoration of plasma von Willebrand factor deficiency is sufficient to correct thrombus formation after gene therapy for severe von Willebrand disease. Arterioscler Thromb Vasc Biol (2008) 1.02
Nanometer-scale organization of the alpha subunits of the receptors for IL2 and IL15 in human T lymphoma cells. J Cell Sci (2008) 1.01
Role of glycoprotein Ibalpha in phagocytosis of platelets by macrophages. Transfusion (2006) 1.01
Laboratory diagnosis and molecular classification of von Willebrand disease. Acta Haematol (2009) 1.01
Class I HLA oligomerization at the surface of B cells is controlled by exogenous beta(2)-microglobulin: implications in activation of cytotoxic T lymphocytes. Int Immunol (2003) 1.01
ADAMTS13 activity to antigen ratio in physiological and pathological conditions associated with an increased risk of thrombosis. Br J Haematol (2007) 1.01
Identification of residues within human glycoprotein VI involved in the binding to collagen: evidence for the existence of distinct binding sites. J Biol Chem (2004) 1.00
Key role of glycoprotein Ib/V/IX and von Willebrand factor in platelet activation-dependent fibrin formation at low shear flow. Blood (2010) 1.00
Phenotypic correction of von Willebrand disease type 3 blood-derived endothelial cells with lentiviral vectors expressing von Willebrand factor. Blood (2006) 0.99
Synergistic effect of thrombin on collagen-induced platelet procoagulant activity is mediated through protease-activated receptor-1. Arterioscler Thromb Vasc Biol (2005) 0.99
A biophysical approach to IL-2 and IL-15 receptor function: localization, conformation and interactions. Immunol Lett (2008) 0.98
Rational humanization of the powerful antithrombotic anti-GPIbalpha antibody: 6B4. Thromb Haemost (2006) 0.98
Antiplatelet drugs. Br J Haematol (2008) 0.98
Principal role of glycoprotein VI in alpha2beta1 and alphaIIbbeta3 activation during collagen-induced thrombus formation. Arterioscler Thromb Vasc Biol (2004) 0.97
Inherited traits affecting platelet function. Blood Rev (2008) 0.97
Model systems of genetically modified platelets. Blood (2011) 0.96
Activation of alphaIIbbeta3 is a sufficient but also an imperative prerequisite for activation of alpha2beta1 on platelets. Blood (2006) 0.95
Factor XIII, clot structure, thrombosis. Thromb Res (2011) 0.95
GPI-microdomains (membrane rafts) and signaling of the multi-chain interleukin-2 receptor in human lymphoma/leukemia T cell lines. Eur J Biochem (2002) 0.93
Monoclonal antibody IAC-1 is specific for activated alpha2beta1 and binds to amino acids 199 to 201 of the integrin alpha2 I-domain. Blood (2004) 0.91
Conformation of the c-Fos/c-Jun complex in vivo: a combined FRET, FCCS, and MD-modeling study. Biophys J (2007) 0.90
Blood platelet biochemistry. Thromb Res (2011) 0.89
The humanized anti-glycoprotein Ib monoclonal antibody h6B4-Fab is a potent and safe antithrombotic in a high shear arterial thrombosis model in baboons. Thromb Haemost (2008) 0.89
Two functional active conformations of the integrin {alpha}2{beta}1, depending on activation condition and cell type. J Biol Chem (2005) 0.89
Von Willebrand factor: drug and drug target. Cardiovasc Hematol Disord Drug Targets (2009) 0.89
Increased plasma von Willebrand factor antigen levels but normal von Willebrand factor cleaving protease (ADAMTS13) activity in preeclampsia. Thromb Haemost (2009) 0.88
Two-sided fluorescence resonance energy transfer for assessing molecular interactions of up to three distinct species in confocal microscopy. Cytometry A (2008) 0.88
Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques. Thromb Haemost (2007) 0.87
Inhibition of platelet glycoprotein Ib and its antithrombotic potential. Curr Pharm Des (2007) 0.87
Improved platelet survival after cold storage by prevention of glycoprotein Ibα clustering in lipid rafts. Haematologica (2012) 0.86
Inhibition of platelet glycoprotein Ib, glycoprotein IIb/IIIa, or both by monoclonal antibodies prevents arterial thrombosis in baboons. Arterioscler Thromb Vasc Biol (2002) 0.86
Thrombotic and fibrinolytic alterations in the aseptic necrosis of femoral head. Blood Coagul Fibrinolysis (2003) 0.86
New insights into von Willebrand disease and platelet function. Semin Thromb Hemost (2012) 0.86
A consensus tetrapeptide selected by phage display adopts the conformation of a dominant discontinuous epitope of a monoclonal anti-VWF antibody that inhibits the von Willebrand factor-collagen interaction. J Biol Chem (2003) 0.86
INF-gamma rearranges membrane topography of MHC-I and ICAM-1 in colon carcinoma cells. Biochem Biophys Res Commun (2002) 0.85
Patient autoantibodies induce platelet destruction signals via raft-associated glycoprotein Ibα and Fc RIIa in immune thrombocytopenia. Haematologica (2013) 0.85
New model of transient strain-dependent autoimmune thrombocytopenia in mice immunized with rat platelets. Exp Hematol (2004) 0.85
Platelet physiology and antiplatelet agents. Clin Chem Lab Med (2010) 0.85
Local elongation of endothelial cell-anchored von Willebrand factor strings precedes ADAMTS13 protein-mediated proteolysis. J Biol Chem (2011) 0.84
Experimental indication for the existence of multiple Trp rotamers in von Willebrand Factor A3 domain. Proteins (2004) 0.84
von Willebrand factor but not alpha-thrombin binding to platelet glycoprotein Ibalpha is influenced by the HPA-2 polymorphism. Arterioscler Thromb Vasc Biol (2003) 0.83
Phage display selection of efficient glutamine-donor substrate peptides for transglutaminase 2. Protein Sci (2006) 0.83
The novel S527F mutation in the integrin beta3 chain induces a high affinity alphaIIbbeta3 receptor by hindering adoption of the bent conformation. J Biol Chem (2009) 0.82
Paratope and epitope mapping of the antithrombotic antibody 6B4 in complex with platelet glycoprotein Ibalpha. J Biol Chem (2007) 0.82
Looking through ion channels: recharged concepts in T-cell signaling. Trends Immunol (2004) 0.82
Enhanced release of IL-6 and IL-8 into tears in various anterior segment eye diseases. Ophthalmic Res (2006) 0.82
The A/T1381 polymorphism in the A1-domain of von Willebrand factor influences the affinity of von Willebrand factor for platelet glycoprotein Ibalpha. Thromb Haemost (2007) 0.81
Paratope determination of the antithrombotic antibody 82D6A3 based on the crystal structure of its complex with the von Willebrand factor A3-domain. J Biol Chem (2005) 0.81
Detection of receptor trimers on the cell surface by flow cytometric fluorescence energy homotransfer measurements. Biochim Biophys Acta (2005) 0.80
Platelet interaction with von Willebrand factor is enhanced by shear-induced clustering of glycoprotein Ibα. Haematologica (2013) 0.80
Non-random distribution of interleukin receptors on the cell surface. Chemphyschem (2009) 0.80
Membrane topography of HLA I, HLA II, and ICAM-1 is affected by IFN-gamma in lipid rafts of uveal melanomas. Biochem Biophys Res Commun (2004) 0.80
Fluorescent labeling of platelets with polyanionic fluorescein derivatives. Anal Quant Cytol Histol (2009) 0.79
Dissecting interacting molecular populations by FRET. Cytometry A (2008) 0.79
Development of a high-throughput ELISA assay for platelet function testing using platelet-rich plasma or whole blood. Thromb Haemost (2010) 0.79
The parasitic hematophagous worm Haemonchus contortus inhibits human platelet aggregation and adhesion: partial purification of a platelet inhibitor. Thromb Haemost (2002) 0.79
Principles of resonance energy transfer. Curr Protoc Cytom (2006) 0.79
Measuring FRET in flow cytometry and microscopy. Curr Protoc Cytom (2006) 0.79
Type 2B von Willebrand disease in seven individuals from three different families: phenotypic and genotypic characterization. Thromb Haemost (2007) 0.79
Laser-induced primary and secondary hemostasis dynamics and mechanisms in relation to selective photothermolysis of port wine stains. J Dermatol Sci (2011) 0.79
Immobilised peptide displaying phages as affinity ligands. Purification of lactoferrin from defatted milk. J Chromatogr A (2005) 0.79
Macroporous monolithic gels, cryogels, with immobilized phages from phage-display library as a new platform for fast development of affinity adsorbent capable of target capture from crude feeds. J Biotechnol (2007) 0.79
Integrin alphaIIbbeta3 and shear-dependent action of glycoprotein Ibalpha stimulate platelet-dependent thrombin formation in stirred plasma. J Lab Clin Med (2003) 0.78
Roles of Src-like adaptor protein 2 (SLAP-2) in GPVI-mediated platelet activation SLAP-2 and GPVI signaling. Thromb Res (2010) 0.78
Distinct spatial relationship of the interleukin-9 receptor with interleukin-2 receptor and major histocompatibility complex glycoproteins in human T lymphoma cells. Chemphyschem (2014) 0.78
Affinity comparison of p3 and p8 peptide displaying bacteriophages using surface plasmon resonance. Anal Chem (2013) 0.78
Computer program for analyzing donor photobleaching FRET image series. Cytometry A (2005) 0.78
Apparent heterogeneity in the pIII-peptide fusion protein in single-phage clones isolated from peptide libraries. Protein Eng Des Sel (2011) 0.78
The GPIbalpha-thrombin interaction: far from crystal clear. Trends Mol Med (2004) 0.78
ICAM-1 inhibits the homocluster formation of MHC-I in colon carcinoma cells. Biochem Biophys Res Commun (2006) 0.78
Levels of von Willebrand factor antigen and von Willebrand factor cleaving protease (ADAMTS13) activity predict clinical events in chronic heart failure. Thromb Haemost (2009) 0.78
Measurement of molecular mobility with fluorescence correlation spectroscopy. Curr Protoc Cytom (2009) 0.77
Nanoparticle energy transfer on the cell surface. J Mol Recognit (2005) 0.77
On the interaction of fluorophore-encapsulating PEGylated lecithin liposomes with hamster and human platelets. Microvasc Res (2009) 0.77
The role of supramolecular protein complexes and membrane potential in transmembrane signaling processes of lymphocytes. Immunol Lett (2005) 0.77
Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibalpha in an enzyme-linked immunosorbent assay-based method: performances in patients with type 2B von Willebrand disease. Br J Haematol (2006) 0.77